Browsing: Immunotherapy

Top Line: Does immunotherapy improve outcomes for patients with locally advanced cervical cancer?The Study: Besides significant advances in radiation techniques,…

Top Line: The disappointment continues for immunotherapy in locally advanced head and neck cancer.The Study: In the phase 3 JAVELIN…

A cohort study tried the strategy of neoadjuvant cemiplimab or pembrolizumab for resectable cutaneous squamous cell carcinoma. After a median…

A meta-analysis of clinical trials evaluating the efficacy of immune checkpoint inhibitors (ICI) for metastasis urothelial carcinoma (there’s been 14,…

The Chinese phase 3 Neotorch trial shows yet again big incremental benefits with adding immune checkpoint inhibition, in this case…

Top Line: What is the response rate of neoadjuvant chemoimmunotherapy for locally advanced cervical cancer?The Study: Concurrent chemoradiation is the…

Top Line: Chemoradiation and maintenance durvalumab remains the standard treatment for unresectable, stage III NSCLC, but multiple trials are exploring…

Top Line: What is the rate of progression free survival after radiation and immunotherapy for stage III NSCLC? The Study:…

A secondary analysis of a small phase 2 trial demonstrating pathologic responses (≤10% viable tumor cells) in three-quarters of patients…

A secondary analysis of a small phase 2 trial demonstrating pathologic responses (≤10% viable tumor cells) in three-quarters of patients…